-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Earlier, HUTCHMED Begins First-In-Human Global Clinical Program For ATTC Candidate HMPL-A251 In Solid Tumors

Benzinga·12/17/2025 07:09:20
語音播報
  • — First-in-human trial of candidate from the next-generation ATTC platform —
  • — Simultaneous China and global clinical development strategy to expedite development process —